Cargando…

Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort

AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m(2)) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between ann...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Canto, Elisa, Elders, Petra J. M., van der Heijden, Amber A., van Ballegooijen, Adriana J., Lissenberg-Witte, Birgit I., Rutters, Femke, Beulens, Joline W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892144/
https://www.ncbi.nlm.nih.gov/pubmed/36347992
http://dx.doi.org/10.1007/s00125-022-05826-y
_version_ 1784881286376062976
author Dal Canto, Elisa
Elders, Petra J. M.
van der Heijden, Amber A.
van Ballegooijen, Adriana J.
Lissenberg-Witte, Birgit I.
Rutters, Femke
Beulens, Joline W. J.
author_facet Dal Canto, Elisa
Elders, Petra J. M.
van der Heijden, Amber A.
van Ballegooijen, Adriana J.
Lissenberg-Witte, Birgit I.
Rutters, Femke
Beulens, Joline W. J.
author_sort Dal Canto, Elisa
collection PubMed
description AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m(2)) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations. RESULTS: After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60–90 ml/min per 1.73 m(2)) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m(2)) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m(2)). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3–30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28). CONCLUSIONS/INTERPRETATION: This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article 10.1007/s00125-022-05826-y contains peer-reviewed but unedited supplementary material.
format Online
Article
Text
id pubmed-9892144
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98921442023-02-03 Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort Dal Canto, Elisa Elders, Petra J. M. van der Heijden, Amber A. van Ballegooijen, Adriana J. Lissenberg-Witte, Birgit I. Rutters, Femke Beulens, Joline W. J. Diabetologia Article AIMS/HYPOTHESIS: Both manifestations of kidney disease in diabetes, reduced eGFR (ml/min per 1.73 m(2)) and increased urinary albumin/creatinine ratio (UACR, mg/mmol), may increase the risk of specific CVD subtypes in adults with diabetes. METHODS: We assessed the prospective association between annually recorded measures of eGFR and UACR and the occurrence of myocardial infarction (MI), CHD, stroke, heart failure (HF) and cardiovascular mortality in 13,657 individuals with diabetes (53.6% male, age 62.3±12.1 years) from the Hoorn Diabetes Care System cohort, using data obtained between 1998 and 2018. Multivariate time-dependent Cox regression models adjusted for cardiovascular risk factors were used to estimate HRs and 95% CI. Associations of eGFR were adjusted for UACR values and vice versa. Effect modification by sex was investigated for all associations. RESULTS: After a mean follow-up period of 7 years, event rates per 1000 person-years were 3.08 for MI, 3.72 for CHD, 1.12 for HF, 0.84 for stroke and 6.25 for cardiovascular mortality. Mildly reduced eGFR (60–90 ml/min per 1.73 m(2)) and moderately to severely reduced eGFR (<59 ml/min per 1.73 m(2)) were associated with higher risks of MI (HR 1.52; 95% CI 1.10, 2.12 and HR 1.69; 95% CI 1.09, 2.64) and CHD (HR 1.67; 95% CI 1.23, 2.26 and HR 2.01; 95% CI 1.34, 3.02) compared with normal eGFR (>90 ml/min per 1.73 m(2)). Mildly reduced eGFR was associated with a higher risk of stroke (HR 2.53; 95% CI 1.27, 5.03). Moderately increased UACR (3–30 mg/mmol) and severely increased UACR (>30 mg/mmol) were prospectively associated with a higher cardiovascular mortality risk in men and women (HR 1.87; 95% CI 1.41, 2.47 and HR 2.78; 95% CI 1.78, 4.34) compared with normal UACR (<3 mg/mmol). Significant effect modification by sex was observed for the association between UACR and HF. Because there were a limited number of HF events within the category of UACR >30 mg/mmol, categories were combined into UACR <3.0 and >3.0 mg/mmol in the stratified analysis. Women but not men with UACR >3.0 mg/mmol had a significantly higher risk of HF compared with normal UACR (HR 2.79; 95% CI 1.47, 5.28). CONCLUSIONS/INTERPRETATION: This study showed differential and independent prospective associations between manifestations of early kidney damage in diabetes and several CVD subtypes, suggesting that regular monitoring of both kidney function measures may help to identify individuals at higher risk of specific cardiovascular events. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version of this article 10.1007/s00125-022-05826-y contains peer-reviewed but unedited supplementary material. Springer Berlin Heidelberg 2022-11-08 2023 /pmc/articles/PMC9892144/ /pubmed/36347992 http://dx.doi.org/10.1007/s00125-022-05826-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Dal Canto, Elisa
Elders, Petra J. M.
van der Heijden, Amber A.
van Ballegooijen, Adriana J.
Lissenberg-Witte, Birgit I.
Rutters, Femke
Beulens, Joline W. J.
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
title Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
title_full Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
title_fullStr Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
title_full_unstemmed Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
title_short Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort
title_sort kidney function measures and cardiovascular outcomes in people with diabetes: the hoorn diabetes care system cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892144/
https://www.ncbi.nlm.nih.gov/pubmed/36347992
http://dx.doi.org/10.1007/s00125-022-05826-y
work_keys_str_mv AT dalcantoelisa kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort
AT elderspetrajm kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort
AT vanderheijdenambera kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort
AT vanballegooijenadrianaj kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort
AT lissenbergwittebirgiti kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort
AT ruttersfemke kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort
AT beulensjolinewj kidneyfunctionmeasuresandcardiovascularoutcomesinpeoplewithdiabetesthehoorndiabetescaresystemcohort